Antiviral treatment of hepatitis B virus-transgenic mice by a marine organism, Styela plicata

World Journal of Gastroenterology

Volumn 12, Issue 25, 2006, Pages 4038-4043

  Wang, Rui ^a   Du, Zhen Lan ^b   Duan, Wen Jun ^a   Zhang, Xin ^a   Zeng, Fan Lin ^a   Wan, Xin Xiang ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b Beijing 307 Hospital   (China)

Author keywords

Chronic hepatitis B; Hepatitis B virus; RT PCR; Styela plicata; Transgenic mice

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS B SURFACE ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 6; LAMIVUDINE; STYELA PLICATA EXTRACT; UNCLASSIFIED DRUG; VIRUS DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; ASCIDIACEA; CONTROLLED STUDY; DIETARY INTAKE; DRUG BLOOD LEVEL; DRUG WITHDRAWAL; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELPER CELL; HEPATITIS B; HEPATITIS B VIRUS; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STYELA PLICATA; TRANSGENIC MOUSE; VIRUS CARRIER; VIRUS REPLICATION;

EID: 33746217604     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i25.4038     Document Type: Article

References (26)

1. Liaw YF. Therapy of chronic hepatitis B: current challenges and opportunities. J Viral Hepat 2002; 9: 393-399
2. Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337: 1733-1745
3. Akbar SM, Yamamoto K, Abe M, Ninomiya T, Tanimoto K, Masumoto T, Michitaka K, Horiike N, Onji M. Potent synergistic effect of sho-saiko-to, a herbal medicine, during vaccine therapy in a murine model of hepatitis B virus carrier. Eur J Clin Invest 1999; 29: 786-792
4. Tanikawa K. Recent advances in antiviral agents: antiviral drug discovery for hepatitis viruses. Curr Pharm Des 2006; 12: 1371-1377
5. Leung N. Nucleoside analogues in the treatment of chronic hepatitis B. J Gastroenterol Hepatol 2000; 15 Suppl: E53-60
6. Chang TT, Lai CL, Chien RN, Guan R, Lim SG, Lee CM, Ng KY, Nicholls GJ, Dent JC, Leung NW. Four years of lamivudine treatment in Chinese patients with chronic hepatitis B. J Gastroenterol Hepatol 2004; 19: 1276-1282
7. Wang JH, Lu SN, Lee CM, Lee JF, Chou YP. Fatal hepatic failure after emergence of the hepatitis B virus mutant during lamivudine therapy in a patient with liver cirrhosis. Scand J Gastroenterol 2002; 37: 366-369
8. Raftos DA, Nair SV, Robbins J, Newton RA, Peters R. A complement component C3-like protein from the tunicate, Styela plicata. Dev Comp Immunol 2002; 26: 307-312
9. Mayer AM, Gustafson KR. Marine pharmacology in 2000: antitumor and cytotoxic compounds. Int J Cancer 2003; 105: 291-299
10. Mayer AM, Gustafson KR. Marine pharmacology in 2001-2: antitumour and cytotoxic compounds. Eur J Cancer 2004; 40: 2676-2704
11. Wan XX, Zhang X, Liu Q, Huang XP, Zeng FL, Wang SN. Inhibitory effect of ethanol extract from Styela plicata on HBsAg and HBeAg in vitro. Zhongguo Haiyang Yaowu 2003; 3: 40-42
12. Jonathan L, Marcy C, Bill S, Claire EP, Judrrh LM, Linda DS, Frank HM, Mark AF. Hepatitis B virus transgenic mouse model of chronic liver disease. Nature Medicine 1999; 5: 907-912
13. Akbar SMF, Onjl M. Hepatitis B virus (HBV) -transgenic mice as a investigative tool to study immunopathology during HBV infection. Int J Exp Path 1998; 79: 279-291
14. Liu GZ, Jia YZ, Wang HM, Xiong YL. Observation on the stability of the replication and generation of HBV gene in transgenic mice. Shiyan Dongwu Kexue Yu Guanli 2001; 18: 1-3
15. Liu MC, Yu M, Zhang NL, Gong WB, Wang Y, Piao WH, Wang QH, Wang GQ. Dynamic analysis of hepatitis B virus DNA and its antigens in 2.2.15 cells. J Viral Hepat 2004; 11: 124-129
16. Guo WC, Mei B, Li YL, Zhang DF. The applied research on fluorogence probe PCR in diagnosing of HBV. Zhonghua Linchuang Yu Weisheng 2004; 3: 305-307
17. Zeng MD, Wang TL, Wang BE. Consensus on evaluation of the diagnosis and efficacy of hepatic fibrosis. Zhenduanxue Lilun Yu Shijian 2002; 1: 191-192
18. Davies-Coleman MT, Beukes DR. Ten years of marine natural products research at Rhodes University. S Afr J Sci 2004; 100: 539-544
19. Fenical W, Jensen PR, Kauffman C, Mayhead SL, Faulkner DJ, Snicich C, Rao MR, Kantorowski EJ, West LM, Strangman WK, Shimizu Y, Li B, Thammana S, Drainville K, Davies-Coleman MT, Kramer RA, Fairchild CR, Rose WC, Wild RC, Vite GD, Peterson PW. New Anticancer Drugs from Cultured and Collected Marine Organisms. Pharm Biol 2003; 41: 6-14
20. Jimenez PC, Fortier SC, Lotufo TMC, Pessoa C, Moraes MEA, de Moraes MO, Costa-Lotufo LV. Biological activity in extracts of ascidians (Tunicata, Ascidiacea) from the northeastern Brazilian coast. J Exp Mar Biol Ecol 2003; 287: 93-102
21. Wang R, Wan XX. The comparison of the inhibitory effect of ethanol extract from different species of ascidean on HBsAg and HBeAg in vitro. Zhongguo Yaolixue Tongbao 2005; 21: 606-608
22. Hu WJ, Wan XX. The screening of effective ingredient for anti-hepatitis B virus from Styela. Plicata. Zhongguo Yiyuan Yaofang Zazhi 2004; 24: 202-203
23. Muraillle E, Leo O. Revisiting the Th1/Th2 Paradigm. Scand J Immunol 1998; 47: 1-9
24. Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell 1994; 76: 241-251
25. Sher A, Coffman RL. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu Rev Immunol 1992; 10: 385-409
26. Dong YH, Xi HL, Yu YY, Wang QH, Jiang K, Li LZ. Effects of oxymatrine on the serum levels of T helper cell 1 and 2 cytokines and the expression of the S gene in hepatitis B virus S gene transgenic mice: A study on the anti-hepatitis B virus mechanism of oxymatrine. J Gastroenterol Hepatol 2002; 17: 1299-1306